c-Abl Phosphorylates MFN2 to Regulate Mitochondrial Morphology in Cells under Endoplasmic Reticulum and Oxidative Stress, Impacting Cell Survival and Neurodegeneration

The endoplasmic reticulum is a subcellular organelle key in the control of synthesis, folding, and sorting of proteins. Under endoplasmic reticulum stress, an adaptative unfolded protein response is activated; however, if this activation is prolonged, cells can undergo cell death, in part due to oxidative stress and mitochondrial fragmentation. Here, we report that endoplasmic reticulum stress activates c-Abl tyrosine kinase, inducing its translocation to mitochondria. We found that endoplasmic reticulum stress-activated c-Abl interacts with and phosphorylates the mitochondrial fusion protein MFN2, resulting in mitochondrial fragmentation and apoptosis. Moreover, the pharmacological or genetic inhibition of c-Abl prevents MFN2 phosphorylation, mitochondrial fragmentation, and apoptosis in cells under endoplasmic reticulum stress. Finally, in the amyotrophic lateral sclerosis mouse model, where endoplasmic reticulum and oxidative stress has been linked to neuronal cell death, we demonstrated that the administration of c-Abl inhibitor neurotinib delays the onset of symptoms. Our results uncovered a function of c-Abl in the crosstalk between endoplasmic reticulum stress and mitochondrial dynamics via MFN2 phosphorylation.

[1]  H. Motaln,et al.  The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies , 2023, Cells.

[2]  J. Marugan,et al.  c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease , 2023, Frontiers in Aging Neuroscience.

[3]  R. Vidal,et al.  The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model , 2022, IBRO neuroscience reports.

[4]  R. Ichiyama,et al.  Caudal–Rostral Progression of Alpha Motoneuron Degeneration in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis , 2022, Antioxidants.

[5]  Noel Southall,et al.  c-Abl Activation Linked to Autophagy-Lysosomal Dysfunction Contributes to Neurological Impairment in Niemann-Pick Type A Disease , 2022, Frontiers in Cell and Developmental Biology.

[6]  T. Tachibana,et al.  c-Src-dependent phosphorylation of Mfn2 regulates endoplasmic reticulum-mitochondria tethering , 2022, bioRxiv.

[7]  N. Mercuri,et al.  Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease , 2021, Progress in Neurobiology.

[8]  Apekshya Panda,et al.  MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations , 2020, Nucleic Acids Res..

[9]  A. Ballabio,et al.  c-Abl Inhibition Activates TFEB and Promotes Cellular Clearance in a Lysosomal Disorder , 2020, iScience.

[10]  G. Kroemer,et al.  Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response , 2020, Nature Communications.

[11]  Gianluca Tomasello,et al.  The Protein Imager: a full-featured online molecular viewer interface with server-side HQ-rendering capabilities , 2020, Bioinform..

[12]  D. Chan,et al.  Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset , 2019, Nature Communications.

[13]  A. S. Gavrish,et al.  Transmission Electron Microscopy Study of Mitochondria in Aging Brain Synapses , 2019, Antioxidants.

[14]  J. Grimm,et al.  SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS , 2019, Scientific Reports.

[15]  S. Yun,et al.  The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson’s disease mouse model , 2018, Human molecular genetics.

[16]  P. Pizzo,et al.  Mitofusin 2: from functions to disease , 2018, Cell Death & Disease.

[17]  Zengqiang Yuan,et al.  c-Abl-mediated Drp1 phosphorylation promotes oxidative stress-induced mitochondrial fragmentation and neuronal cell death , 2017, Cell Death & Disease.

[18]  C. Hetz,et al.  Fine-Tuning ER Stress Signal Transducers to Treat Amyotrophic Lateral Sclerosis , 2017, Front. Mol. Neurosci..

[19]  Ahmed Negida,et al.  C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease. , 2017, CNS & neurological disorders drug targets.

[20]  Ryuji Kaji,et al.  The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis , 2017, Science Translational Medicine.

[21]  Dustin J Maly,et al.  Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes. , 2017, Cell metabolism.

[22]  C. Hetz,et al.  The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial Bioenergetics , 2017, Front. Oncol..

[23]  J. Troncoso,et al.  Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration. , 2016, The Journal of clinical investigation.

[24]  A. Pendergast,et al.  Multifunctional Abl kinases in health and disease , 2016, Journal of Cell Science.

[25]  Eric Chevet,et al.  Proteostasis control by the unfolded protein response , 2015, Nature Cell Biology.

[26]  F. Court,et al.  Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling , 2015, Front. Cell. Neurosci..

[27]  L. Scorrano,et al.  Extracellular Regulated Kinase Phosphorylates Mitofusin 1 to Control Mitochondrial Morphology and Apoptosis , 2015, Molecular cell.

[28]  Elisa Greotti,et al.  Mitofusin 2 ablation increases endoplasmic reticulum–mitochondria coupling , 2015, Proceedings of the National Academy of Sciences.

[29]  C. Dieterich,et al.  Mitofusin 2 is required to maintain mitochondrial coenzyme Q levels , 2015, The Journal of cell biology.

[30]  T. Dawson,et al.  The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease , 2014, Scientific Reports.

[31]  N. Inestrosa,et al.  EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers , 2014, PloS one.

[32]  Deming Zhao,et al.  c-Abl Tyrosine Kinase Mediates Neurotoxic Prion Peptide-Induced Neuronal Apoptosis via Regulating Mitochondrial Homeostasis , 2014, Molecular Neurobiology.

[33]  Jean Y. J. Wang The Capable ABL: What Is Its Biological Function? , 2014, Molecular and Cellular Biology.

[34]  E. Masliah,et al.  c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease. , 2014, Human molecular genetics.

[35]  C. Moussa,et al.  Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models. , 2013, Human molecular genetics.

[36]  Jun Wang,et al.  Role of ABL family kinases in cancer: from leukaemia to solid tumours , 2013, Nature Reviews Cancer.

[37]  G. Dorn,et al.  PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria , 2013, Science.

[38]  Mohanad Mossalam,et al.  Enhanced and selective killing of chronic myelogenous leukemia cells with an engineered BCR-ABL binding protein and imatinib. , 2012, Molecular pharmaceutics.

[39]  F. Urano,et al.  c-Abl Inhibition Delays Motor Neuron Degeneration in the G93A Mouse, an Animal Model of Amyotrophic Lateral Sclerosis , 2012, PloS one.

[40]  T. Veenstra,et al.  Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. , 2012, Molecular cell.

[41]  G. Cesareni,et al.  Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases? , 2012, International journal of cell biology.

[42]  D. Green,et al.  A unified model of mammalian BCL-2 protein family interactions at the mitochondria. , 2011, Molecular cell.

[43]  E. Toledo,et al.  c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice , 2011, Neurobiology of Aging.

[44]  Jun-bing Wu,et al.  The c-Abl-MST1 Signaling Pathway Mediates Oxidative Stress-Induced Neuronal Cell Death , 2011, The Journal of Neuroscience.

[45]  A. J. Valente,et al.  Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease , 2011, The Journal of Neuroscience.

[46]  Benedikt Westermann,et al.  Mitochondrial fusion and fission in cell life and death , 2010, Nature Reviews Molecular Cell Biology.

[47]  J. Colicelli,et al.  ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity , 2010, Science Signaling.

[48]  J. Troncoso,et al.  Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function , 2010, Proceedings of the National Academy of Sciences.

[49]  D. Green,et al.  Resistance to caspase-independent cell death requires persistence of intact mitochondria. , 2010, Developmental cell.

[50]  A. Koleske,et al.  Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts , 2009, Journal of Cell Science.

[51]  L. Scorrano,et al.  Mitofusin-2 regulates mitochondrial and endoplasmic reticulum morphology and tethering: the role of Ras. , 2009, Mitochondrion.

[52]  L. Scorrano,et al.  Mitofusin 2 tethers endoplasmic reticulum to mitochondria , 2008, Nature.

[53]  Julio D Amigo,et al.  Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann‐Pick type C disease , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  N. Inestrosa,et al.  STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. , 2008, Brain : a journal of neurology.

[55]  G. Perkins,et al.  Mitochondrial fragmentation in neurodegeneration , 2008, Nature Reviews Neuroscience.

[56]  S. Kaech,et al.  Culturing hippocampal neurons , 2006, Nature Protocols.

[57]  D. Chan Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.

[58]  H. McBride,et al.  Activated Mitofusin 2 Signals Mitochondrial Fusion, Interferes with Bax Activation, and Reduces Susceptibility to Radical Induced Depolarization*[boxs] , 2005, Journal of Biological Chemistry.

[59]  K. Kosik,et al.  Activation of the neuronal c-Abl tyrosine kinase by amyloid-β-peptide and reactive oxygen species , 2004, Neurobiology of Disease.

[60]  Kelvin K. Tsai,et al.  c-Abl stabilizes p73 by a phosphorylation-augmented interaction. , 2003, Cancer research.

[61]  H. Duewel,et al.  Two Distinct Phosphorylation Pathways Have Additive Effects on Abl Family Kinase Activation , 2003, Molecular and Cellular Biology.

[62]  G. Superti-Furga,et al.  Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase , 2003, Cell.

[63]  D. Kufe,et al.  Abrogation of the cell death response to oxidative stress by the c-Abl tyrosine kinase inhibitor STI571. , 2003, Molecular pharmacology.

[64]  Erik E. Griffin,et al.  Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development , 2003, The Journal of cell biology.

[65]  N. Narula,et al.  Targeting of the c-Abl Tyrosine Kinase to Mitochondria in Endoplasmic Reticulum Stress-Induced Apoptosis , 2001, Molecular and Cellular Biology.

[66]  W. Miller,et al.  The substrate specificity of the catalytic domain of Abl plays an important role in directing phosphorylation of the adaptor protein Crk. , 2000, Cellular signalling.

[67]  L. Tsai,et al.  Cables Links Cdk5 and c-Abl and Facilitates Cdk5 Tyrosine Phosphorylation, Kinase Upregulation, and Neurite Outgrowth , 2000, Neuron.

[68]  D. Baltimore,et al.  Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation , 1998, Neuron.

[69]  R. Weichselbaum,et al.  Role for c-Abl tyrosine kinase in growth arrest response to DNA damage , 1996, Nature.

[70]  C. Sawyers,et al.  The nuclear tyrosine kinase c-abl negatively regulates cell growth , 1994, Cell.

[71]  P. J. Welch,et al.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.

[72]  P. Chinnery,et al.  Disturbed mitochondrial dynamics and neurodegenerative disorders , 2015, Nature Reviews Neurology.

[73]  R. Bowser,et al.  Altered subcellular distribution of c-Abl in Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[74]  J. Zhu,et al.  Death by Abl: a matter of location. , 2004, Current topics in developmental biology.

[75]  M. Zachary,et al.  Department of , 1993 .